The European Medicines Agency (EMEA) has granted marketing authorisation to two swine flu vaccines: Focetria produced by Novartis and Pandemrix produced by GlaxoSmithKline, which is classified by the EU as a bioweapon.
The authorisation has been given in spite of the fact the vaccines have not been tested.
The authorisation has been given in spite of the fact the vaccines have not been tested.
"There is currently no clinical experience with Focetria (H1N1) in adults, including the elderly, children or adolescents," says the EMEA on its pandemic influenza H1N1 website after giving approval to the vaccine on September 24th.
